NIH-funded research R01 grant

Improving Newborn Screening with Whole Genome Sequencing

Official title: Massively Parallel Biochemical Annotation of Missense DNA Variants to Support Newborn Screening by Whole Genome Sequencing

Funded at University of Washington · NIH-11176114 · Data updated 2026-11-12

This project aims to make newborn screening more accurate by better understanding genetic changes found through whole genome sequencing.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 23, 2024
Project endJune 30, 2028
Funding year2025
Award (this year)$643,802
NIH project number5R01HD115326-02
Project IDNIH-11176114 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research does not directly involve patient participation, but its future impact is on newborns who undergo genetic screening.

Less likely to help

Patients who are not newborns or those not undergoing whole genome sequencing for screening would not directly benefit from this specific research.

What this research studies

Current newborn screening checks for treatable conditions using blood tests, but many diseases lack clear markers. Whole genome sequencing offers a new way to screen newborns, but it can sometimes miss important genetic changes that are not well understood. This project is developing a new method to quickly and affordably identify which genetic changes might cause problems. We are creating a library of all possible protein changes and testing them in human cells to see how they affect protein function, which will help us better interpret genetic results for newborns.

Why it matters

Potential benefit: If successful, this work could lead to more comprehensive and accurate newborn screening, allowing for earlier diagnosis and treatment of many pediatric diseases.

How similar studies have gone: While the concept of newborn screening is well-established, this specific approach to massively parallel biochemical annotation of DNA variants for newborn sequencing is a novel technological development.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Gelb, Michael H — University of Washington
  • Study coordinator: Gelb, Michael H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.